Search
for
Sort by
Research 721–750 of 1000+
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata
- Impact of Sleep Disturbance, Physical Function, Depression and Anxiety on Male Lower Urinary Tract Symptoms: Results from the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN)
- Frontal edema due to mesotherapy for androgenetic alopecia: A case series
- Neutrophil extracellular traps impair regeneration
- Brigham Eyebrow Tool for Alopecia: A Reliable Assessment of Eyebrow Alopecia Areata
- Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Quality of life, psychosocial difficulties and bullying in paediatric patients with alopecia areata: a European cross-sectional study
- Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial
- Scalp hair parameter changes in transgender individuals commencing gender-affirming hormone therapy: A 24-week prospective observational study
- The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources
- Increased CRHR1 expression on monocytes from patients with AA enables a pro‐inflammatory response to corticotrophin‐releasing hormone
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- Use of diphenylcyclopropenone for alopecia areata treatment during pregnancy
- Spironolactone in hidradenitis suppurativa: a single-center
- Cell type‐specific actions of thyroid hormones in nonalcoholic steatohepatitis and liver fibrosis
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
- Immunohistochemical, pharmacovigilance, and omics analyses reveal the involvement of ATP-sensitive K+ channel subunits in cancers: role in drug–disease interactions
- Supplementation and hair growth: A retrospective chart review of patients with alopecia and laboratory abnormalities
- The association between frontal fibrosing alopecia, sunscreen, and moisturizers: A systematic review and meta-analysis
- Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial
- Multiple basal cell carcinomas in a patient with myotonic dystrophy type 1
- Beeinflussen Medikamente gegen das benigne Prostatasyndrom Stimmung oder Kognition?
- Systemic scleroderma and lupus panniculitis with atypical clinical features: A case report and comprehensive review
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Frontal fibrosing alopecia in males: A systematic review
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- With or Without Silicones? A Comprehensive Review of Their Role in Hair Care
- Perceived Stigma Among Adults With Alopecia Areata in the United States